Crossject (ALCJ) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.640x

Based on the latest financial reports, Crossject (ALCJ) has a cash flow conversion efficiency ratio of 0.640x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.12 Million ≈ $-3.64 Million USD) by net assets (€-4.87 Million ≈ $-5.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALCJ defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Crossject - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Crossject's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Crossject Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Crossject ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Grupo Ortiz Properties Socimi MC:YGOP	0.009x
Thai Optical Group Public Company Limited BK:TOG	0.073x
Kino Polska TV SA WAR:KPL	0.086x
Mdevice KQ:226590	0.341x
Luda Technology Group Limited NYSE MKT:LUD	0.262x
Piscines Desjoyaux SA PA:ALPDX	0.136x
District Metals Corp V:DMX	-0.027x
Lyko Group A ST:LYKO-A	-1.102x

Annual Cash Flow Conversion Efficiency for Crossject (2012–2025)

The table below shows the annual cash flow conversion efficiency of Crossject from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see ALCJ company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€-4.87 Million ≈ $-5.69 Million	€-6.35 Million ≈ $-7.42 Million	1.304x	-56.19%
2024-12-31	€-2.67 Million ≈ $-3.13 Million	€-7.96 Million ≈ $-9.30 Million	2.977x	+152.94%
2023-12-31	€-5.27 Million ≈ $-6.16 Million	€-6.20 Million ≈ $-7.25 Million	1.177x	+162.23%
2022-12-31	€2.69 Million ≈ $3.14 Million	€-5.08 Million ≈ $-5.94 Million	-1.891x	-270.39%
2021-12-31	€-5.48 Million ≈ $-6.41 Million	€-6.08 Million ≈ $-7.11 Million	1.110x	-77.03%
2020-12-31	€-1.13 Million ≈ $-1.32 Million	€-5.46 Million ≈ $-6.39 Million	4.833x	+364.36%
2019-12-31	€3.01 Million ≈ $3.52 Million	€-5.51 Million ≈ $-6.44 Million	-1.828x	+62.27%
2018-12-31	€1.65 Million ≈ $1.93 Million	€-8.02 Million ≈ $-9.37 Million	-4.845x	-492.85%
2017-12-31	€6.09 Million ≈ $7.11 Million	€-4.97 Million ≈ $-5.82 Million	-0.817x	-16.62%
2016-12-31	€6.28 Million ≈ $7.35 Million	€-4.40 Million ≈ $-5.15 Million	-0.701x	-28.56%
2015-12-31	€8.80 Million ≈ $10.29 Million	€-4.80 Million ≈ $-5.61 Million	-0.545x	-149.64%
2014-12-31	€14.48 Million ≈ $16.93 Million	€-3.16 Million ≈ $-3.70 Million	-0.218x	+78.53%
2013-12-31	€947.65K ≈ $1.11 Million	€-964.00K ≈ $-1.13 Million	-1.017x	-440.48%
2012-12-31	€-1.90 Million ≈ $-2.23 Million	€-569.06K ≈ $-665.29K	0.299x	--

About Crossject

PA:ALCJ France Medical Instruments & Supplies

Market Cap

$117.41 Million

€100.42 Million EUR

Market Cap Rank

#19177 Global

#288 in France

Share Price

€1.89

Change (1 day)

-0.74%

52-Week Range

€1.40 - €2.69

All Time High

€10.40